Article and Video CATEGORIES
Dr. Marco Ruiz is a Medical Oncologist in Hematologic Cancers specializing in leukemia, lymphoma, myelodysplastic syndrome, myelofibrosis, HIV related malignancies, stem cell transplants, geriatric oncology, and palliative medicine at the Miami Cancer Institute in Miami, Florida. He is also an experienced bone marrow transplant specialist and is active in cancer research. Growing up the son of a nurse, Dr. Ruiz knew at a young age that he wanted to pursue a career in medicine. But it was his father’s battle with cancer that sparked a passion for helping patients with the disease.
In this series Ibrutinib Idelalisib, Dr. Ruiz shares information regarding Chronic Lymphocytic Leukemia & Non-Hodgkin Lymphoma, (Leucemia crónica linfocítica y linfoma no Hodgkin). This video discusses "What are the risks and benefits of Ibrutinib and Idelalisib? How do you manage the side effects of the new kinase inhibitors?" (¿Cuáles son los riesgos y beneficios de ibrutinib y de idelalisib? ¿Cómo manejamos los efectos secundarios de los nuevos inhibidores de la tirosina cinasa?)
We would like to thank the following company for their support of this program:
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi sbunit and welcome to Grace. I'm sorry about your mom and you need to be here looking for answers. Unfortunately there just aren't good answers to these questions. But yes...
As a follow up to my original question, the specific mutations my mom has are S768l and G719S. It’s very difficult finding concrete information regarding these mutations and treatment outcomes. Was...
Hi patneo and welcome to Grace. I'm so sorry your wife is going through this. It isn't possible or even legal to give advice to someone online unless it's in a...
Will doing an ct pet scan to look blood clot in lungs plus onc will be issuing an light dosage of Pemetrexed and carboplatin for a course and after that an...
Hi patneo,
I'm sorry but your wife's situation sounds too complicated to make judgments about possible best practices. I think our language barrier may be complicating our communication as well...because...